View in EDS

Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19.

Saved in:
Bibliographic Details
Title: Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19.
Authors: Milross L; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK., Hunter B; Newcastle University Biosciences Institute, Newcastle upon Tyne, UK; Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK., McDonald D; Newcastle University Biosciences Institute, Newcastle upon Tyne, UK; Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK., Merces G; Newcastle University Biosciences Institute, Newcastle upon Tyne, UK; Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK., Thomson A; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK; Newcastle University Biosciences Institute, Newcastle upon Tyne, UK; Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK., Hilkens CMU; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK., Wills J; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK., Rees P; Department of Biomedical Engineering, Swansea University, Wales, UK; Imaging Platform, Broad Institute of MIT and Harvard, 415 Main Street, Boston, Cambridge, MA, USA., Jiwa K; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Cooper N; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Majo J; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Ashwin H; York Biomedical Research Institute, Hull York Medical School, University of York, York, UK., Duncan CJA; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Kaye PM; York Biomedical Research Institute, Hull York Medical School, University of York, York, UK., Bayraktar OA; Wellcome Sanger Institute, Hinxton, Cambridge, UK., Filby A; Newcastle University Biosciences Institute, Newcastle upon Tyne, UK; Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK. Electronic address: andrew.filby@newcastle.ac.uk., Fisher AJ; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK; Institute of Transplantation, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Electronic address: a.j.fisher@newcastle.ac.uk.
Source: EBioMedicine [EBioMedicine] 2024 Jan; Vol. 99, pp. 104945. Date of Electronic Publication: 2023 Dec 23.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38142637
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Milross+L%22">Milross L</searchLink>; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Hunter+B%22">Hunter B</searchLink>; Newcastle University Biosciences Institute, Newcastle upon Tyne, UK; Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22McDonald+D%22">McDonald D</searchLink>; Newcastle University Biosciences Institute, Newcastle upon Tyne, UK; Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Merces+G%22">Merces G</searchLink>; Newcastle University Biosciences Institute, Newcastle upon Tyne, UK; Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Thomson+A%22">Thomson A</searchLink>; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK; Newcastle University Biosciences Institute, Newcastle upon Tyne, UK; Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Hilkens+CMU%22">Hilkens CMU</searchLink>; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Wills+J%22">Wills J</searchLink>; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Rees+P%22">Rees P</searchLink>; Department of Biomedical Engineering, Swansea University, Wales, UK; Imaging Platform, Broad Institute of MIT and Harvard, 415 Main Street, Boston, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Jiwa+K%22">Jiwa K</searchLink>; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Cooper+N%22">Cooper N</searchLink>; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Majo+J%22">Majo J</searchLink>; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Ashwin+H%22">Ashwin H</searchLink>; York Biomedical Research Institute, Hull York Medical School, University of York, York, UK.<br /><searchLink fieldCode="AU" term="%22Duncan+CJA%22">Duncan CJA</searchLink>; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK; Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Kaye+PM%22">Kaye PM</searchLink>; York Biomedical Research Institute, Hull York Medical School, University of York, York, UK.<br /><searchLink fieldCode="AU" term="%22Bayraktar+OA%22">Bayraktar OA</searchLink>; Wellcome Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Filby+A%22">Filby A</searchLink>; Newcastle University Biosciences Institute, Newcastle upon Tyne, UK; Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK. Electronic address: andrew.filby@newcastle.ac.uk.<br /><searchLink fieldCode="AU" term="%22Fisher+AJ%22">Fisher AJ</searchLink>; Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK; Institute of Transplantation, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Electronic address: a.j.fisher@newcastle.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101647039%22">EBioMedicine</searchLink> [EBioMedicine] 2024 Jan; Vol. 99, pp. 104945. <i>Date of Electronic Publication: </i>2023 Dec 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101647039 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3964 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523964%22">23523964 </searchLink><i>NLM ISO Abbreviation: </i>EBioMedicine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38142637
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ebiom.2023.104945
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104945
    Titles:
      – TitleFull: Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Milross L
      – PersonEntity:
          Name:
            NameFull: Hunter B
      – PersonEntity:
          Name:
            NameFull: McDonald D
      – PersonEntity:
          Name:
            NameFull: Merces G
      – PersonEntity:
          Name:
            NameFull: Thomson A
      – PersonEntity:
          Name:
            NameFull: Hilkens CMU
      – PersonEntity:
          Name:
            NameFull: Wills J
      – PersonEntity:
          Name:
            NameFull: Rees P
      – PersonEntity:
          Name:
            NameFull: Jiwa K
      – PersonEntity:
          Name:
            NameFull: Cooper N
      – PersonEntity:
          Name:
            NameFull: Majo J
      – PersonEntity:
          Name:
            NameFull: Ashwin H
      – PersonEntity:
          Name:
            NameFull: Duncan CJA
      – PersonEntity:
          Name:
            NameFull: Kaye PM
      – PersonEntity:
          Name:
            NameFull: Bayraktar OA
      – PersonEntity:
          Name:
            NameFull: Filby A
      – PersonEntity:
          Name:
            NameFull: Fisher AJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024 Jan
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2352-3964
          Numbering:
            – Type: volume
              Value: 99
          Titles:
            – TitleFull: EBioMedicine
              Type: main
ResultId 1